MDxHealth SA
NASDAQ:MDXH

Watchlist Manager

MDxHealth SA

NASDAQ:MDXH

Watchlist

Price: 2.63 USD 2.33% Market Closed

Market Cap: 71.8m USD

Have any thoughts about
MDxHealth SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 2.63 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

MDXH Alert

MDxHealth SA

2.63

+0.06 (+2.33%)

52 Week Range	2.2 4.48
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

MDxHealth SA

What unique competitive advantages
does MDxHealth SA hold over its rivals?

What risks and challenges
does MDxHealth SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of MDxHealth SA.

What unique competitive advantages
does MDxHealth SA hold over its rivals?

What risks and challenges
does MDxHealth SA face in the near future?

Has there been any significant insider trading activity
in MDxHealth SA recently?

Summarize the latest earnings call
of MDxHealth SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for MDxHealth SA.

Provide P/S
for MDxHealth SA.

Provide P/E
for MDxHealth SA.

Provide P/B
for MDxHealth SA.

Show me price targets
for MDxHealth SA made by professional analysts.

What are the Revenue projections
for MDxHealth SA?

How accurate were the past Revenue estimates
for MDxHealth SA?

What are the Net Income projections
for MDxHealth SA?

How accurate were the past Net Income estimates
for MDxHealth SA?

What are the EPS projections
for MDxHealth SA?

How accurate were the past EPS estimates
for MDxHealth SA?

What are the EBIT projections
for MDxHealth SA?

How accurate were the past EBIT estimates
for MDxHealth SA?

Compare the revenue forecasts
for MDxHealth SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of MDxHealth SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of MDxHealth SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of MDxHealth SA compared to its peers.

Compare the P/E ratios
of MDxHealth SA against its peers.

Discuss the investment returns and shareholder value creation
comparing MDxHealth SA with its peers.

Analyze the financial leverage
of MDxHealth SA compared to its main competitors.

Show all profitability ratios
for MDxHealth SA.

Provide ROE
for MDxHealth SA.

Provide ROA
for MDxHealth SA.

Provide Net Margin
for MDxHealth SA.

Show all solvency ratios
for MDxHealth SA.

What is the historical Revenue growth
over the last 5 years for MDxHealth SA?

What is the historical Net Income growth
over the last 5 years for MDxHealth SA?

What is the current Free Cash Flow
of MDxHealth SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for MDxHealth SA.

P/S
Price to Sales

0.6

Current

1.7

Median

7.7

Industry

Lower than median

Lower than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S

0.6

Market Cap

71.8m USD

Revenue

119.9m USD

All Countries

Forward Multiples

			Market Cap	P/S
BE	M	MDxHealth SA NASDAQ:MDXH	71.8m USD	0.6
US		Abbvie Inc NYSE:ABBV	341.9B USD	6.2
US		Amgen Inc NASDAQ:AMGN	180.5B USD	5.8
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	127.8B USD	9.5
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	123.3B USD	11.9
US		Gilead Sciences Inc NASDAQ:GILD	104.5B USD	3.8
US	E	Epizyme Inc F:EPE	94.1B EUR	1 981.8
AU		CSL Ltd ASX:CSL	142.3B AUD	6.5
US	S	Seagen Inc F:SGT	39.3B EUR	19.1
US	P	Palatin Technologies Inc LSE:0KF3	38.5B USD	6 513.5
US		Alnylam Pharmaceuticals Inc NASDAQ:ALNY	35.4B USD	15.1

				Revenue Growth
BE	M	MDxHealth SA NASDAQ:MDXH	Average P/S: 779.4 0.6	61%
US		Abbvie Inc NYSE:ABBV	6.2	18%
US		Amgen Inc NASDAQ:AMGN	5.8	26%
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	9.5	28%
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	11.9	34%
US		Gilead Sciences Inc NASDAQ:GILD	3.8	8%
US	E	Epizyme Inc F:EPE	1 981.8	N/A
AU		CSL Ltd ASX:CSL	6.5	23%
US	S	Seagen Inc F:SGT	19.1	118%
US	P	Palatin Technologies Inc LSE:0KF3	6 513.5	707%
US		Alnylam Pharmaceuticals Inc NASDAQ:ALNY	15.1	93%

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/S

0.8

2-Years Forward

P/S

0.7

3-Years Forward

P/S

0.6

MDxHealth SA
NASDAQ:MDXH

P/S
Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

MDxHealth SA NASDAQ:MDXH

P/S Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

MDxHealth SA
NASDAQ:MDXH

P/S
Price to Sales